$GILD Up to date company activities and other impo
Post# of 89388
Posted On: 12/19/2013 11:43:05 AM
$GILD Up to date company activities and other important information about $GILD
$GILD
DD Notes ~ http://www.ddnotesmaker.com/GILD
##### recent news/filings ~ source: finance.yahoo.com
Thu, 19 Dec 2013 15:58:19 GMT ~ Here's What This Annual 20% Gainer Has Been Buying
- Might you profit from the growth of 3-D printing or LED lighting?
read full: http://www.fool.com/investing/general/2013/12...lnk0000001
*********************************************************
Thu, 19 Dec 2013 13:30:43 GMT ~ Cowen Forecasts Top 10 Potential Biotech Surprises for 2014
read full: http://247wallst.com/healthcare-business/2013...-for-2014/
*********************************************************
Thu, 19 Dec 2013 11:27:56 GMT ~ The Zacks Analyst Blog Highlights: Gilead Sciences, Euronet Worldwide, Moody's, FleetCor Technologies and American Express
- The Zacks Analyst Blog Highlights: Gilead Sciences, Euronet Worldwide, Moody's, FleetCor Technologies and American Express
read full: http://finance.yahoo.com/news/zacks-analyst-b...56573.html
*********************************************************
Thu, 19 Dec 2013 01:43:02 GMT ~ Taking HIV prevention pill may not encourage risky sex - US study
- Taking a pill as a preventive measure against HIV infection may not encourage people at high risk for the disease to engage in risky sexual behavior, according to a new U.S. study meant to address fears about its use. The research, published in the Public Library of Science journal PLOS ONE, builds on the 2010 landmark study that found Gilead Sciences Inc's Truvada - a pill already used widely to treat the human immunodeficiency virus - was more than 90 percent effective at preventing HIV infections among test subjects who took the drug as prescribed. "There has been a concern that really anything we do to prevent HIV in high-risk individuals could lead people to feel more secure and have riskier sex," said Dr. Robert Grant of the Gladstone Institute of Virology and Immunology in San Francisco, one of the study's authors. Grant's lab went back to its landmark iPrEx trial, a three-year study involving nearly 2,500 HIV negative gay men and male-to-female transgendered women in six countries.
read full: http://finance.yahoo.com/news/taking-hiv-prev...02527.html
*********************************************************
Wed, 18 Dec 2013 23:25:47 GMT ~ Stellar hepatitis C data puts Gilead farther ahead of pack
- Gilead Sciences Inc released impressive late-stage data Wednesday for its once-daily combination pill to treat hepatitis C, advancing its lead in the race to develop new, all-oral treatments for the liver disease, and pushed up its timeline for seeking U.S. approval. Gilead unveiled initial results from three Phase III studies that demonstrated cure rates well in excess of 90 percent with as little as 8 weeks of treatment for some patients, and its share price rose 5 percent. The findings were achieved without the use of either injectable interferon, which causes miserable flu-like symptoms, or ribavirin, an antiviral pill that carries its own troublesome side effects. "The results certainly raise the bar and dim the outlook for competitors such as AbbVie, Bristol-Myers and Boehringer Ingelheim," Sanford Bernstein analyst Geoffrey Porges said of rival all-oral programs in development that require more drugs and more pills than Gilead's to achieve similarly high cure rates.
read full: http://finance.yahoo.com/news/gilead-seek-oka...47627.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=GILD&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=GILD&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GILD/company-info
Ticker: $GILD
OTC Market Place: Not Available
CIK code: 0000882095
Company name: Gilead Sciences, Inc.
Company website: http://www.gilead.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/GILD/filings
Latest financials: http://www.otcmarkets.com/stock/GILD/financials
Latest news: http://www.otcmarkets.com/stock/GILD/news - http://finance.yahoo.com/q/h?s=GILD+Headlines
Major holdings: http://data.cnbc.com/quotes/GILD/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=GILD+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/GILD.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=GILD
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Gilead+Sciences%2C...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ces%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.gilead.com
Alexa: http://www.alexa.com/siteinfo/http://www.gilead.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.gilead.com
http://www.pennystocktweets.com/stocks/profile/GILD
##### last known share structure ~ source: otcmarkets.com
Market Value: $105,034,413,761 a/o Dec 18, 2013
Shares Outstanding: 1,533,349,106 a/o Oct 18, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/GILD
$GILD
DD Notes ~ http://www.ddnotesmaker.com/GILD
##### recent news/filings ~ source: finance.yahoo.com
Thu, 19 Dec 2013 15:58:19 GMT ~ Here's What This Annual 20% Gainer Has Been Buying
- Might you profit from the growth of 3-D printing or LED lighting?
read full: http://www.fool.com/investing/general/2013/12...lnk0000001
*********************************************************
Thu, 19 Dec 2013 13:30:43 GMT ~ Cowen Forecasts Top 10 Potential Biotech Surprises for 2014
read full: http://247wallst.com/healthcare-business/2013...-for-2014/
*********************************************************
Thu, 19 Dec 2013 11:27:56 GMT ~ The Zacks Analyst Blog Highlights: Gilead Sciences, Euronet Worldwide, Moody's, FleetCor Technologies and American Express
- The Zacks Analyst Blog Highlights: Gilead Sciences, Euronet Worldwide, Moody's, FleetCor Technologies and American Express
read full: http://finance.yahoo.com/news/zacks-analyst-b...56573.html
*********************************************************
Thu, 19 Dec 2013 01:43:02 GMT ~ Taking HIV prevention pill may not encourage risky sex - US study
- Taking a pill as a preventive measure against HIV infection may not encourage people at high risk for the disease to engage in risky sexual behavior, according to a new U.S. study meant to address fears about its use. The research, published in the Public Library of Science journal PLOS ONE, builds on the 2010 landmark study that found Gilead Sciences Inc's Truvada - a pill already used widely to treat the human immunodeficiency virus - was more than 90 percent effective at preventing HIV infections among test subjects who took the drug as prescribed. "There has been a concern that really anything we do to prevent HIV in high-risk individuals could lead people to feel more secure and have riskier sex," said Dr. Robert Grant of the Gladstone Institute of Virology and Immunology in San Francisco, one of the study's authors. Grant's lab went back to its landmark iPrEx trial, a three-year study involving nearly 2,500 HIV negative gay men and male-to-female transgendered women in six countries.
read full: http://finance.yahoo.com/news/taking-hiv-prev...02527.html
*********************************************************
Wed, 18 Dec 2013 23:25:47 GMT ~ Stellar hepatitis C data puts Gilead farther ahead of pack
- Gilead Sciences Inc released impressive late-stage data Wednesday for its once-daily combination pill to treat hepatitis C, advancing its lead in the race to develop new, all-oral treatments for the liver disease, and pushed up its timeline for seeking U.S. approval. Gilead unveiled initial results from three Phase III studies that demonstrated cure rates well in excess of 90 percent with as little as 8 weeks of treatment for some patients, and its share price rose 5 percent. The findings were achieved without the use of either injectable interferon, which causes miserable flu-like symptoms, or ribavirin, an antiviral pill that carries its own troublesome side effects. "The results certainly raise the bar and dim the outlook for competitors such as AbbVie, Bristol-Myers and Boehringer Ingelheim," Sanford Bernstein analyst Geoffrey Porges said of rival all-oral programs in development that require more drugs and more pills than Gilead's to achieve similarly high cure rates.
read full: http://finance.yahoo.com/news/gilead-seek-oka...47627.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=GILD&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=GILD&...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/GILD/company-info
Ticker: $GILD
OTC Market Place: Not Available
CIK code: 0000882095
Company name: Gilead Sciences, Inc.
Company website: http://www.gilead.com
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/GILD/filings
Latest financials: http://www.otcmarkets.com/stock/GILD/financials
Latest news: http://www.otcmarkets.com/stock/GILD/news - http://finance.yahoo.com/q/h?s=GILD+Headlines
Major holdings: http://data.cnbc.com/quotes/GILD/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=GILD+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/GILD.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=GILD
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Gilead+Sciences%2C...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...ces%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.gilead.com
Alexa: http://www.alexa.com/siteinfo/http://www.gilead.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.gilead.com
http://www.pennystocktweets.com/stocks/profile/GILD
##### last known share structure ~ source: otcmarkets.com
Market Value: $105,034,413,761 a/o Dec 18, 2013
Shares Outstanding: 1,533,349,106 a/o Oct 18, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/GILD
(0)
(0)